Enzalutamide

Posted on 16th September 2020 by Karen Jennison

Grey

Brand Name(s):Xtandi

Indication:Prostate cancer – metastatic castration-resistant

Rationale:2

Considered:May-13

Review Date:Jul-24

Comments:
NICE TA580
Enzalutamide for hormone-relapsed nonmetastatic
prostate cancer
May 2019